Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial

BACKGROUND: As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessation moti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Res Notes
Asıl Yazarlar: Nichols, John A. A., Grob, Paul, Kite, Wendy, Williams, Peter, de Lusignan, Simon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5653992/
https://ncbi.nlm.nih.gov/pubmed/29061161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2831-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller